经验

Smart Share Global – $150 Million IPO

March 31, 2021

Cooley advised the underwriters on Smart Share Global’s $150 million initial public offering of 17,650,000 American Depositary Shares. Goldman Sachs, Citigroup Global Markets  and China Renaissance Securities (Hong Kong) Limited acted as joint bookrunners and for the offering. Smart Share Global, whose securities now trade on the Nasdaq Global Select Market under the symbol EM, is a consumer tech company providing mobile device charging service. Partners Will Cai, Michael Yu and David Peinsipp led the Cooley team.

Related contacts

蔡华
合伙人, 香港
余仙
香港办事处主管合伙人, 香港
David Peinsipp
Partner, 旧金山
李正洋
国际法律项目经理, 香港
张捷
顾问, 香港

Related Practices & Industries

TI Cloud – HK$559.4 Million IPO

July 1, 2022

Cooley advised TI Cloud, a cloud-native customer contact solution provider, on its HK$559.4 million ($71.7 million) initial public offering of 43,530,000 shares (subject to an overallotment option to issue an additional 6,529,400 shares), which now trade on the Hong Kong Stock Exchange. Partners Michael Yu and Will Cai led the Cooley team advising TI Cloud, which also included Jie Zhang, Ying Liu, Keke Wu, Zhengyang Li, Lingyi Lin and Philip Kwan. 
Read more

Related contacts

余仙
香港办事处主管合伙人, 香港
蔡华
合伙人, 香港
Francis Wheeler
Senior Counsel, 科罗拉多
张捷
顾问, 香港
刘颖
律师, 香港
李正洋
国际法律项目经理, 香港
Rick Jantz
Associate, 洛杉矶
Philip Kwan
Senior Legal Assistant, 香港

Related Practices & Industries

Cryofocus Medtech – HK$210 Million IPO

January 5, 2023

Cooley advised the joint sponsors and underwriters of Cryofocus Medtech’s HK$210 million ($27 million) initial public offering of 11,110,000 H Shares on the Hong Kong Stock Exchange.
Read more

Related contacts

余仙
香港办事处主管合伙人, 香港
刘毅铭
上海办事处主管合伙人, 上海
蔡华
合伙人, 香港
杨凯婷
顾问律师, 香港
王一盈
顾问律师, 上海
徐云翔
律师, 上海
刘学谦
律师, 香港
吴茜
律师, 上海
李正洋
国际法律项目经理, 香港

Butong Group Announces HK$781.84 Million IPO

September 23, 2025

Cooley advised Butong Group in connection with its HK$781.84 million initial public offering (IPO).

Read more

Related contacts

蔡华
合伙人, 香港
余仙
香港办事处主管合伙人, 香港
张捷
顾问, 香港
段棣淳
律师, 北京
于子程
Associate, 香港
Karen Tsai
Special Counsel, 华盛顿特区
刘学谦
律师, 香港
Juan Nascimbene
Associate, 伦敦
李正洋
国际法律项目经理, 香港
Blake Cao
Senior Legal Assistant, 北京
Philip Kwan
Senior Legal Assistant, 香港

Related Practices & Industries

Leads Biolabs Announces HK$1.29 Billion IPO

July 25, 2025

Cooley advised Nanjing Leads Biolabs Co. (Leads Biolabs), a clinical-stage biotechnology company that discovers, develops and commercializes new therapies in oncology, autoimmune and other severe diseases, on its HK$1.29 billion initial public offering (IPO).

Read more

Related contacts

余仙
香港办事处主管合伙人, 香港
刘毅铭
上海办事处主管合伙人, 上海
杨凯婷
顾问律师, 香港
王一盈
顾问律师, 上海
徐云翔
律师, 上海
刘学谦
律师, 香港
吴茜
律师, 上海
Daniel Zheng
Associate, 上海
李正洋
国际法律项目经理, 香港
Cindy Pan
International Legal Project Manager, 香港
Zoe Wang
International Legal Project Manager, 上海
Francis Wheeler
Senior Counsel, 科罗拉多
Mark Windfeld-Hansen
Senior Counsel, 帕罗奥图
Vince Sampson
Special Counsel, 华盛顿特区
Karen Tsai
Special Counsel, 华盛顿特区

Related Practices & Industries

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.